Risk of death and adverse effects in patients on Liothyronine: a multi-source systematic review and meta-analysis AbstractContext. Although some patients with hypothyroidism prefer combination therapy with Liothyronine (LT3) and Levothyroxine (LT4), the safety of LT3 r

Where did the deep antagonism towards T3/Liothyronine come from?

A much appreciated paper.

#medsky
#Liothyronine
#T3MeToo
#NHS
#Thyroid
#Cynomel
@drpetetaylor.bsky.social
@samanthajwathen.bsky.social
@mary-saunders.bsky.social
@thyroidmary.bsky.social

academic.oup.com/jcem/advance...

📢 Important Medication Update
The Cynomel brand of liothyronine is being discontinued in France from 31 Oct 2025. The French Medicines Agency has confirmed an alternative will be made available.

Read more here:
🔗 thyroiduk.org/important-up...
#ThyroidHealth #Cynomel #Liothyronine #PatientInfo

Le #Cynomel, un médicament de Sanofi contre l’hypothyroïdie, ne sera plus commercialisé en France (Le géant pharmaceutique #Sanofi arrêtera de commercialiser le Cynomel,